224 related articles for article (PubMed ID: 10321759)
1. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene polymorphisms in inflammatory bowel disease.
Louis E; Satsangi J; Roussomoustakaki M; Parkes M; Fanning G; Welsh K; Jewell D
Gut; 1996 Nov; 39(5):705-10. PubMed ID: 9014770
[TBL] [Abstract][Full Text] [Related]
3. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
4. Genetic markers in ulcerative colitis. Why are the results different?
Peña AS; Crusius JB; Meuwissen SG
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):405-7. PubMed ID: 10321757
[No Abstract] [Full Text] [Related]
5. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
6. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
[TBL] [Abstract][Full Text] [Related]
7. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).
Bouma G; Xia B; Crusius JB; Bioque G; Koutroubakis I; Von Blomberg BM; Meuwissen SG; Peña AS
Clin Exp Immunol; 1996 Mar; 103(3):391-6. PubMed ID: 8608636
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunological markers in pouchitis.
Brett PM; Yasuda N; Yiannakou JY; Herbst F; Ellis HJ; Vaughan R; Nicholls RJ; Ciclitira PJ
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):951-5. PubMed ID: 8930557
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis.
Castro-Santos P; Suarez A; Mozo L; Gutierrez C
Clin Immunol; 2007 Jan; 122(1):108-14. PubMed ID: 17070109
[TBL] [Abstract][Full Text] [Related]
10. Genetic markers may predict disease behavior in patients with ulcerative colitis.
Roussomoustakaki M; Satsangi J; Welsh K; Louis E; Fanning G; Targan S; Landers C; Jewell DP
Gastroenterology; 1997 Jun; 112(6):1845-53. PubMed ID: 9178675
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients.
Borgmann S; Endisch G; Hacker UT; Song BS; Fricke H
Am J Kidney Dis; 2003 May; 41(5):933-42. PubMed ID: 12722027
[TBL] [Abstract][Full Text] [Related]
12. P-ANCA in monozygotic twins with inflammatory bowel disease.
Yang P; Järnerot G; Danielsson D; Tysk C; Lindberg E
Gut; 1995 Jun; 36(6):887-90. PubMed ID: 7615278
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis].
González Sarmiento R; Araoz P; Rodríguez R; Oliveira A; Feranández Blanco I; Sánchez Rodríguez A
Med Clin (Barc); 1999 Jun; 112(20):778-9. PubMed ID: 10422059
[TBL] [Abstract][Full Text] [Related]
14. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
[TBL] [Abstract][Full Text] [Related]
15. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms.
Hacker UT; Bidlingmaier C; Gomolka M; Keller E; Eigler A; Hartmann G; Folwaczny C; Fricke H; Albert E; Loeschke K; Endres S
Eur J Clin Invest; 1998 Mar; 28(3):214-9. PubMed ID: 9568467
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
18. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin (IL)-1beta, IL-1 receptor antagonist and IL-4 gene polymorphisms in ulcerative colitis in the Chinese].
Peng Z; Hu P; Cui Y; Li C
Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):248-51. PubMed ID: 12133437
[TBL] [Abstract][Full Text] [Related]
20. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease.
Settin A; Abdel-Hady H; El-Baz R; Saber I
Pediatr Cardiol; 2007; 28(5):363-71. PubMed ID: 17607501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
